"mTOR is an exciting new target protein in cancer management and seems to act as a 'master switch' because of its involvement in a number of cancers," says Dr Alison Jones (UCL Institute of Health). "The potential for effectively targeting this pathway in breast cancer is very exciting."
Read: Herald Scotland
Close
